A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

NCT01476696 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Prasugrel

Sponsor

Eli Lilly and Company

Collaborators

[object Object]